Westbourne Investments »

Jazz Pharmaceuticals shares owned by Westbourne Investments

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Westbourne Investments from 13F filings

Historical chart of Westbourne Investments investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Westbourne Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Westbourne Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $238k 1.4k 170.00

More positions owned by Westbourne Investments

NVIDIA Corporation (NVDA)
Ge Aerospace Com New (GE)
Qualcomm (QCOM)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Spdr Series Trust State Street Spd (BIL)
Micron Technology (MU)
Dell Technologies CL C (DELL)
Vertiv Holdings Com Cl A (VRT)
Spdr Gold Tr Gold Shs (GLD)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)

View all positions for Westbourne Investments

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Dimensional Fund Advisors
Capital World Investors
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
GoldenTree Asset Management
Swedbank AB
Citadel Advisors
Renaissance Technologies

View all funds holding Jazz Pharmaceuticals